|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 401 to 487 out of 487 for Sost

<< First    < Previous  |  Next >    Last >>
0.025s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Javaheri B
Year: 2019
Journal: Am J Pathol
Title: Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids.
Volume: 189
Issue: 4
Pages: 753-761
Regulatory Region
Type: enhancer
Organism: mouse, laboratory
Allele
Name: sclerostin; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Inducible, Recombinase
Allele
Name: sclerostin; targeted mutation 1, Chris Paszty
Allele Type: Targeted
Attribute String: Null/knockout
Genotype
Symbol: Tg(RP11-209M4)AGglo/?
Background: FVB-Tg(RP11-209M4)4Gglo
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Tg(RP11-209M4)AGglo/Tg(RP11-209M4)AGglo
Background: FVB-Tg(RP11-209M4)4Gglo
Zygosity: hm
Has Mutant Allele: true
Allele
Name: sclerostin; endonuclease-mediated mutation 5, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Genotype
Symbol: Sost/Sost
Background: involves: 129/Sv * Black Swiss
Zygosity: hm
Has Mutant Allele: true
DO Term
DO Term
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Allele
Name: sclerostin; targeted mutation 1, Velocigene
Allele Type: Targeted
Attribute String: Null/knockout, Reporter
Allele
Name: regulatory region 20; targeted mutation 1.1, Velocigene
Allele Type: Targeted
Attribute String: Modified regulatory region, Null/knockout
Allele
Name: sclerostin; targeted mutation 1.1, Ozgene
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: sclerostin; endonuclease-mediated mutation 4, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Humanized sequence, Inserted expressed sequence
Allele
Name: transgene insertion 1, Teresita Bellido
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
Allele
Name: sclerostin; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Humanized sequence, Inserted expressed sequence
Allele
Name: sclerostin; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Transgene
Type: transgene
Organism: mouse, laboratory
Genotype
Symbol: Sost/Sost
Background: involves: C57BL/6NTac
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rr20/Rr20
Background: involves: 129S6/SvEvTac * C57BL/6NTac
Zygosity: hm
Has Mutant Allele: true
DO Term
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Allele
Name: sclerostin; targeted mutation 1, Yasuhiro Kobayashi
Allele Type: Targeted
Attribute String: Null/knockout, Reporter
Strain
Attribute String: transgenic, coisogenic, mutant strain
Allele
Name: transgene insertion, Alexander G Robling
Allele Type: Transgenic
Attribute String: Humanized sequence, Inserted expressed sequence
Publication  
First Author: Bullock WA
Year: 2019
Journal: iScience
Title: Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo.
Volume: 20
Pages: 205-215
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Publication
First Author: Rhee Y
Year: 2011
Journal: J Bone Miner Res
Title: PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Volume: 26
Issue: 5
Pages: 1035-46
Publication  
First Author: He G
Year: 2017
Journal: Bone Res
Title: Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth.
Volume: 5
Pages: 17016
Strain
Attribute String: congenic, mutant strain, transgenic
Strain
Attribute String: coisogenic, mutant strain, transgenic
Allele
Name: transgene insertion, Gabriela G Loots
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
Genotype
Symbol: Tg(RP11-209M4)AGglo/?
Background: involves: C57BL/6 * FVB
Zygosity: ot
Has Mutant Allele: true
Publication
First Author: Delgado-Calle J
Year: 2017
Journal: J Bone Miner Res
Title: Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
Volume: 32
Issue: 3
Pages: 522-535
Publication
First Author: Yanagita M
Year: 2004
Journal: Biochem Biophys Res Commun
Title: USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney.
Volume: 316
Issue: 2
Pages: 490-500
Protein Domain
Type: Family
Description: This sclerostin family consists of sclerostin and sclerostin domain-containing protein 1. Sclerostin (SOST) is thought to suppress bone formation. Mutations of the SOST gene lead to sclerosteosis, a progressive sclerosing bone dysplasia with an autosomal recessive mode of inheritance. Radiologically, it is characterised by a generalised hyperostosis and sclerosis leading to a markedly thickened and sclerotic skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients []. Sclerostin domain-containing protein 1, also known as USAG1, is a bone morphogenetic protein antagonist [].
Strain
Attribute String: transgenic, mutant strain, coisogenic
Genotype
Symbol: Tg(RP11-209M4*)#Gglo/?
Background: FVB-Tg(RP11-209M4*)#Gglo
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Tg(RP11-209M4*)#Gglo/Tg(RP11-209M4*)#Gglo
Background: FVB-Tg(RP11-209M4*)#Gglo
Zygosity: hm
Has Mutant Allele: true
Publication
First Author: Kaneko K
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Integrin αv in the mechanical response of osteoblast lineage cells.
Volume: 447
Issue: 2
Pages: 352-7
Publication
First Author: Sato T
Year: 2020
Journal: Nat Commun
Title: A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction.
Volume: 11
Issue: 1
Pages: 3282
Publication
First Author: Song D
Year: 2021
Journal: Sci Rep
Title: Functional interaction between Wnt and Bmp signaling in periosteal bone growth.
Volume: 11
Issue: 1
Pages: 10782
Publication  
First Author: Sebastian A
Year: 2018
Journal: Metabolism
Title: Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
Volume: 80
Pages: 38-47
Publication
First Author: Liu H
Year: 2022
Journal: Nat Commun
Title: Osteocyte CIITA aggravates osteolytic bone lesions in myeloma.
Volume: 13
Issue: 1
Pages: 3684
Protein
Organism: Mus musculus/domesticus
Length: 206  
Fragment?: false
HT Experiment
Series Id: GSE14242
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
Publication
First Author: Delgado-Calle J
Year: 2022
Journal: FASEB J
Title: The Notch pathway regulates the bone gain induced by PTH anabolic signaling.
Volume: 36
Issue: 3
Pages: e22196
Publication
First Author: Canalis E
Year: 2016
Journal: Am J Physiol Endocrinol Metab
Title: Canonical Notch activation in osteocytes causes osteopetrosis.
Volume: 310
Issue: 2
Pages: E171-82
Publication  
First Author: Kondoh S
Year: 2014
Journal: Bone
Title: Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.
Volume: 60
Pages: 68-77
Publication  
First Author: Baroi S
Year: 2021
Journal: Bone
Title: PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss.
Volume: 147
Pages: 115913
Publication  
First Author: Zanotti S
Year: 2017
Journal: Bone
Title: Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes.
Volume: 103
Pages: 159-167
Publication
First Author: Shiraki M
Year: 2019
Journal: FASEB J
Title: Deficiency of stress-associated gene Nupr1 increases bone volume by attenuating differentiation of osteoclasts and enhancing differentiation of osteoblasts.
Volume: 33
Issue: 8
Pages: 8836-8852
Publication
First Author: Grimston SK
Year: 2012
Journal: PLoS One
Title: Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice.
Volume: 7
Issue: 9
Pages: e44222
Publication  
First Author: Movérare-Skrtic S
Year: 2023
Journal: EBioMedicine
Title: B4GALNT3 regulates glycosylation of sclerostin and bone mass.
Volume: 91
Pages: 104546
Publication  
First Author: Martineau C
Year: 2014
Journal: Physiol Rep
Title: Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation.
Volume: 2
Issue: 10
Publication
First Author: Lau KH
Year: 2013
Journal: Am J Physiol Endocrinol Metab
Title: Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity.
Volume: 305
Issue: 2
Pages: E271-81
Publication
First Author: Powell WF Jr
Year: 2011
Journal: J Endocrinol
Title: Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses.
Volume: 209
Issue: 1
Pages: 21-32
Publication
First Author: Homer-Bouthiette C
Year: 2014
Journal: J Biol Chem
Title: Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis.
Volume: 289
Issue: 52
Pages: 36303-14
Publication
First Author: Meury T
Year: 2010
Journal: Mol Cell Biol
Title: Nuclear alpha NAC influences bone matrix mineralization and osteoblast maturation in vivo.
Volume: 30
Issue: 1
Pages: 43-53
Publication  
First Author: Xu C
Year: 2021
Journal: Front Physiol
Title: TGF-Beta Receptor II Is Critical for Osteogenic Progenitor Cell Proliferation and Differentiation During Postnatal Alveolar Bone Formation.
Volume: 12
Pages: 721775
Publication
First Author: Rhee Y
Year: 2013
Journal: J Biol Chem
Title: Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Volume: 288
Issue: 41
Pages: 29809-20
Publication
First Author: Maridas DE
Year: 2017
Journal: J Endocrinol
Title: IGFBP-4 regulates adult skeletal growth in a sex-specific manner.
Volume: 233
Issue: 1
Pages: 131-144
Publication  
First Author: Staines KA
Year: 2020
Journal: Biosci Rep
Title: Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
Volume: 40
Issue: 1
Publication  
First Author: Morse A
Year: 2020
Journal: Bone
Title: Increased anabolic bone response in Dkk1 KO mice following tibial compressive loading.
Volume: 131
Pages: 115054
Publication
First Author: Maeda A
Year: 2015
Journal: J Biol Chem
Title: WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling.
Volume: 290
Issue: 22
Pages: 14004-18
Publication  
First Author: Gerbaix M
Year: 2015
Journal: Bone
Title: Periostin expression contributes to cortical bone loss during unloading.
Volume: 71
Pages: 94-100
Publication
First Author: Kaneko K
Year: 2011
Journal: J Bone Miner Res
Title: Physiological function of the angiotensin AT1a receptor in bone remodeling.
Volume: 26
Issue: 12
Pages: 2959-66
Publication
First Author: Rahman S
Year: 2013
Journal: Endocrinology
Title: Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton.
Volume: 154
Issue: 8
Pages: 2687-701
Publication
First Author: You L
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Zinc finger protein 467 regulates Wnt signaling by modulating the expression of sclerostin in adipose derived stem cells.
Volume: 456
Issue: 2
Pages: 598-604
Publication
First Author: Remoli C
Year: 2015
Journal: J Bone Miner Res
Title: Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Volume: 30
Issue: 6
Pages: 1030-43
Publication
First Author: Chan WCW
Year: 2017
Journal: Hum Mol Genet
Title: Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia.
Volume: 26
Issue: 23
Pages: 4572-4587
Publication
First Author: Sun N
Year: 2019
Journal: J Biol Chem
Title: Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.
Volume: 294
Issue: 25
Pages: 9722-9733
Publication    
First Author: Castro-Mollo M
Year: 2021
Journal: Elife
Title: The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.
Volume: 10
Publication
First Author: Nakatani T
Year: 2018
Journal: J Bone Miner Res
Title: The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Volume: 33
Issue: 7
Pages: 1362-1375
Publication
First Author: Lloyd SA
Year: 2013
Journal: Bone
Title: Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.
Volume: 57
Issue: 1
Pages: 76-83
Publication  
First Author: Ohori F
Year: 2019
Journal: J Immunol Res
Title: Effect of TNF-α-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement.
Volume: 2019
Pages: 9716758
Publication  
First Author: Lau KW
Year: 2016
Journal: Bone
Title: Conditional deletion of IGF-I in osteocytes unexpectedly accelerates bony union of the fracture gap in mice.
Volume: 92
Pages: 18-28
Publication
First Author: Kramer I
Year: 2012
Journal: J Bone Miner Res
Title: Mef2c deletion in osteocytes results in increased bone mass.
Volume: 27
Issue: 2
Pages: 360-73
Publication
First Author: Zhao G
Year: 2020
Journal: J Bone Miner Res
Title: CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.
Volume: 35
Issue: 11
Pages: 2289-2300
Publication
First Author: Xiong J
Year: 2015
Journal: PLoS One
Title: Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
Volume: 10
Issue: 9
Pages: e0138189
Publication
First Author: Ben-awadh AN
Year: 2014
Journal: Endocrinology
Title: Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
Volume: 155
Issue: 8
Pages: 2797-809
Publication
First Author: Collins JN
Year: 2013
Journal: Endocrinology
Title: Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.
Volume: 154
Issue: 4
Pages: 1400-13
Publication
First Author: Boudin E
Year: 2013
Journal: Bone
Title: Mutations in sFRP1 or sFRP4 are not a common cause of craniotubular hyperostosis.
Volume: 52
Issue: 1
Pages: 292-5
Publication  
First Author: Raju R
Year: 2023
Journal: Front Physiol
Title: Profiles of Wnt pathway gene expression during tooth morphogenesis.
Volume: 14
Pages: 1316635
Publication
First Author: Kao RS
Year: 2013
Journal: Bone
Title: Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
Volume: 55
Issue: 2
Pages: 277-87
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use